Blog
RSS FeedPosted by Michael Wonder on 14 Dec 2024
Deal struck to secure place of eczema drug on PBS
13 December 2024 - Health Minister Mark Butler has struck a deal to secure the place of a “life-changing” eczema ...
Posted by Michael Wonder on 12 Dec 2024
Outcome statements for October 2024 stakeholder meetings: oral contraceptives and migraine
9 December 2024 - The Outcome Statements are now available for the Oral Contraceptives Stakeholder Meeting held on 10 October 2024 ...
Posted by Michael Wonder on 10 Dec 2024
Moderna’s mRNA vaccines to be exempted from advisory committee scrutiny under $2 billion Morrison era deal
10 December 2024 - Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems. ...
Posted by Michael Wonder on 07 Dec 2024
2023-24 financial results for cost recovery activities for listing medicines on the PBS and designated vaccines on the NIP
4 December 2024 - The PBS and NIP Cost Recovery Implementation Statement has been updated to include 2023-24 end of ...
Posted by Michael Wonder on 06 Dec 2024
Agenda for the December 2024 PBAC intracycle meeting
6 December 2024 - The agenda for the December 2024 PBAC intracycle meeting is now available. ...
Posted by Michael Wonder on 06 Dec 2024
Jessica Lawrence’s meds cost her family $75k a year because they’re not listed on the PBS
6 November 2024 - Medications that are subsidised for cancer sufferers are critical to Jess Lawrence’s wellbeing, but because the 25-year-old ...
Posted by Michael Wonder on 03 Dec 2024
HTA Policy and Methods Review update
3 December 2024 - The Minister for Health and Aged Care, the Hon Mark Butler MP has announced the Implementation Advisory ...
Posted by Michael Wonder on 01 Dec 2024
Update on the March 2025 meeting
28 November 2024 - As announced by the Minister on 6 November 2024, to process the unprecedented number of submissions for ...
Posted by Michael Wonder on 01 Dec 2024
Changes to the PBS listings for Opdualag and Vyxeos
1 December 2024 - As of 1 December 2024, combination chemotherapy medicines, Opdualag and Vyxeos, will be transitioned from the Highly ...
Posted by Michael Wonder on 01 Dec 2024
Schedule of Pharmaceutical Benefits - 1 December 2024
1 December 2024 - The December 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Dec 2024
Agenda for the March 2025 PBAC meeting (version 1)
28 November 2024 - The agenda for the March 2025 PBAC meeting is now available. ...
Posted by Michael Wonder on 01 Dec 2024
Life changing endometriosis treatment now cheaper
1 December 2024 - For the first time in three decades, women living with endometriosis will now have access to ...
Posted by Michael Wonder on 01 Dec 2024
Voters clamour for affordable health in election lead-up
30 November 2024 - Threats and delays to affordable medicine access underscore an appetite for higher health spending, with polling placing ...
Posted by Michael Wonder on 01 Dec 2024
DUSC utilisation analysis public release documents (June 2024) update
22 November 2024 - The utilisation analysis public release documents from the June 2024 DUSC meeting are now available. ...
Posted by Michael Wonder on 29 Nov 2024
Update from the PBAC (November 2024)
28 November 2024 - An update from the Chair and Deputy Chair of the PBAC is now available. ...